Longaeva Partners’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.61M Buy
+943,418
New +$1.93M 0.03% 256

Other funds holding IPSC

Longaeva Partners's IPSC Position: Q3 2026 in Review

Longaeva Partners opened a new position in Century Therapeutics (IPSC) in Q3 2026: 943,418 shares worth $1.61M. The stake represents 0.03% of the portfolio and ranks #256 among its holdings.

102 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.

  • Longaeva Partners held 943,418 shares of Century Therapeutics worth $1.61M as of Q3 2026.
  • Century Therapeutics was a new Longaeva Partners position in Q3 2026.
  • Century Therapeutics made up 0.03% of Longaeva Partners's portfolio in Q3 2026, its #256 holding.
  • 102 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.

Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.